ReviewBlood and lymphatic cancer : targets and therapy2021

Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence.

Galia Stemer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.